Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Sunshine Biopharma Inc
SBFMCurrent price
3.3 USD
+0.02 USD (+0.61%)
Last closed
2.83 USD
Company
www.sunshinebiopharma.com
ISIN
US8677814035
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
3 428 152 USD
Yield for 12 month
-99.56 %
1Y
3Y
5Y
10Y
15Y
SBFM
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida. Address: 333 Las Olas Way, Fort Lauderdale, FL, United States, 33301
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
300 USDP/E ratio
–Dividend Yield
–Current Year
+24 092 787 USD
Last Year
+4 345 603 USD
Current Quarter
+9 303 067 USD
Last Quarter
+7 541 046 USD
Current Year
+8 190 024 USD
Last Year
+1 696 575 USD
Current Quarter
+2 305 387 USD
Last Quarter
+2 311 719 USD
Key Figures SBFM
1 year
3 years
5 years
10 years
EBITDA
-4 400 769 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.91 %
PEG Ratio
–
Return On Equity TTM
-15.79 %
Wall Street Target Price
300 USD
Revenue TTM
30 481 982 USD
Book Value
20.06 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
67.3 %
Dividend Yield
–
Gross Profit TTM
1 696 575 USD
Earnings per share
-378.25 USD
Diluted Eps TTM
-378.25 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-12.07 %
Dividend Analytics SBFM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SBFM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
08.08.2024
Dividend Date
06.04.2020
Stock Valuation SBFM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
39.4772
Price Sales TTM
0.1125
Enterprise Value EBITDA
-7.7324
Price Book MRQ
0.146
Financials SBFM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SBFM
For 52 weeks
2.42 USD
780.2 USD
50 Day MA
4.36 USD
Shares Short Prior Month
216 187
200 Day MA
167.2 USD
Short Ratio
1.67
Shares Short
245 276
Short Percent
20.07 %
BeatStart